Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on October 30, 2026

Oct. 30, 2026

Gix Internet: deliverz.ai Granted Patent in South Korea, Expanding International Navigation IP Protection

Indeterminate GlobeNewswire

Oct. 30, 2026

CN Declares Fourth-Quarter 2026 Dividend

Indeterminate GlobeNewswire

Oct. 30, 2026

Le CN déclare un dividende pour le quatrième trimestre de 2026

Indeterminate GlobeNewswire

Oct. 30, 2026

Braveheart Bio to Host Webinar – HCM Spotlight: Advancing a Next-Generation Cardiac Myosin Inhibitor – with Key Opinion Leader Discussion on November 6, 2026

Indeterminate GlobeNewswire

Oct. 30, 2026

Braveheart Bio Announces Upcoming Presentations at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

Oct. 30, 2026

Stallion Uranium Announces Strategic Technical Partnership with Axiom Exploration Group and Corporate Update

Indeterminate GlobeNewswire

Oct. 30, 2026

CN Delivers Strong Third Quarter Performance

Indeterminate GlobeNewswire

Oct. 30, 2026

Le CN affiche un solide rendement au troisième trimestre

Indeterminate GlobeNewswire

Oct. 30, 2026

Celestica Announces TSX Acceptance of Normal Course Issuer Bid

Indeterminate GlobeNewswire

Oct. 30, 2026

Organic Remedies Donates $110,000 to Protect Vulnerable Children in Pennsylvania

Indeterminate GlobeNewswire

Oct. 30, 2026

Alterity Therapeutics Releases Appendix 4C – Q1 FY27 Quarterly Cash Flow Report & Corporate Update

Indeterminate GlobeNewswire

Oct. 30, 2026

Alta Equipment Group Announces Date of Third Quarter 2026 Financial Results Release, Conference Call and Webcast

Indeterminate GlobeNewswire

Oct. 30, 2026

Syndax Announces Participation in November Investor Conferences

Indeterminate GlobeNewswire

Oct. 30, 2026

J & J SNACK FOODS SCHEDULES FOURTH QUARTER and FISCAL YEAR EARNINGS CONFERENCE CALL AND WEBCAST

Indeterminate GlobeNewswire

Oct. 30, 2026

Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint

Indeterminate GlobeNewswire

Oct. 30, 2026

Quebec home prices show wide range of affordability per square foot

Indeterminate GlobeNewswire

Oct. 30, 2026

Les prix des propriétés au Québec révèlent d’importants écarts d’abordabilité au pied carré

Indeterminate GlobeNewswire

Oct. 30, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date

Indeterminate GlobeNewswire

Oct. 30, 2026

Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization

Indeterminate GlobeNewswire

Oct. 30, 2026

Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA

Indeterminate GlobeNewswire